cdmo.directory
← Compare landing

AXOlabs vs Biospring

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axolabs/biospring

CategoryAXOlabsBiospring
Listed sitebothcdmo
SummaryIntegrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.Global CDMO leader in nucleic acid manufacturing and analysis (mRNA, ASO, siRNA, guide RNA, oligonucleotides) with nearly three decades of expertise, GMP certification since 2007, and support for 9 commercial programs across all clinical phases.
Services
  • Bioinformatics & Data Science
  • High-Throughput Screening
  • Target Identification & Validation
  • Discovery Research
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • In Vitro Pharmacology
  • Oligonucleotide Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • Process Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Stability Testing & Storage
  • Quality Control Testing
Modalities
  • Oligonucleotide
  • mRNA
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Petaluma, Petaluma, California, USA
  • Berlin, Berlin, Berlin, Germany
  • Kulmbach, Kulmbach, Bavaria, Germany
  • Headquarters
Certifications
  • GLP · Identifier: Statement of GLP Compliance (06 Dec 2024)
  • GMP · Identifier: Certificate of GMP Compliance (Regierung von Oberfranken, 14 Oct 2024)
  • GMP · Identifier: GMP certified since 2007
  • FDA · Identifier: FDA inspected
  • ANVISA · Identifier: ANVISA inspected
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.